Literature DB >> 21279471

A mathematical model of HIV dynamics in the presence of a rescuing virus with replication deficiency.

Elias Zintzaras1, Axel Kowald.   

Abstract

Recently, an enzyme (Cre recombinase) has been developed by directed evolution that successfully removes the HIV genome from the nuclear DNA of infected cells. To explore this idea further, we hypothesized that a replication deficient virus (called "police virus"), added externally, can deliver such a recombinase which excises the integrated HIV DNA from the genome of infected cells. Such a "police virus" could attack and remove the integrated provirus which is not possible using contemporary strategies. The hypothesis was tested by developing a mathematical model that describes the dynamics of virus-host cell interaction and the consequences of introducing the "police virus". The simulations show that such a therapeutic vector may eradicate all HIV viruses from the system in the long term. All components of the HIV infection (free virus, latently, and actively infected cells) can be cleared and the system ends up only with susceptible CD4+ cells. The proposed model may provide new insights in the dynamical behavior and future alternative treatments of HIV.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21279471     DOI: 10.1007/s12064-011-0119-y

Source DB:  PubMed          Journal:  Theory Biosci        ISSN: 1431-7613            Impact factor:   1.919


  32 in total

1.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

Review 2.  Modelling viral and immune system dynamics.

Authors:  Alan S Perelson
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

Review 3.  Experimental approaches to the study of HIV-1 latency.

Authors:  Yefei Han; Megan Wind-Rotolo; Hung-Chih Yang; Janet D Siliciano; Robert F Siliciano
Journal:  Nat Rev Microbiol       Date:  2007-02       Impact factor: 60.633

4.  Emergence of HIV-1 drug resistance during antiretroviral treatment.

Authors:  Libin Rong; Zhilan Feng; Alan S Perelson
Journal:  Bull Math Biol       Date:  2007-04-21       Impact factor: 1.758

Review 5.  The challenge of finding a cure for HIV infection.

Authors:  Douglas D Richman; David M Margolis; Martin Delaney; Warner C Greene; Daria Hazuda; Roger J Pomerantz
Journal:  Science       Date:  2009-03-06       Impact factor: 47.728

6.  Population dynamics of immune responses to persistent viruses.

Authors:  M A Nowak; C R Bangham
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

7.  Lethal mutagenesis in a structured environment.

Authors:  Shelby H Steinmeyer; Claus O Wilke
Journal:  J Theor Biol       Date:  2009-07-21       Impact factor: 2.691

Review 8.  Modeling HIV persistence, the latent reservoir, and viral blips.

Authors:  Libin Rong; Alan S Perelson
Journal:  J Theor Biol       Date:  2009-06-17       Impact factor: 2.691

9.  Fighting a virus with a virus: a dynamic model for HIV-1 therapy.

Authors:  Tomás Revilla; Gisela García-Ramos
Journal:  Math Biosci       Date:  2003-10       Impact factor: 2.144

10.  Modeling the long-term control of viremia in HIV-1 infected patients treated with antiretroviral therapy.

Authors:  Michele Di Mascio; Ruy M Ribeiro; Martin Markowitz; David D Ho; Alan S Perelson
Journal:  Math Biosci       Date:  2004 Mar-Apr       Impact factor: 2.144

View more
  2 in total

1.  Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized mice.

Authors:  Ilona Hauber; Helga Hofmann-Sieber; Jan Chemnitz; Danilo Dubrau; Janet Chusainow; Rolf Stucka; Philip Hartjen; Axel Schambach; Patrick Ziegler; Karl Hackmann; Evelin Schröck; Udo Schumacher; Christoph Lindner; Adam Grundhoff; Christopher Baum; Markus G Manz; Frank Buchholz; Joachim Hauber
Journal:  PLoS Pathog       Date:  2013-09-26       Impact factor: 6.823

Review 2.  Assessing the cost effectiveness of pre-exposure prophylaxis for HIV prevention in the US.

Authors:  Fred J Hellinger
Journal:  Pharmacoeconomics       Date:  2013-12       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.